EUVIMEDEUVIMED entdecken
Crossref

The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer

Yutong Zhao, Yuanyang Wang, Xiangyu Zhang, Lin Chen, Cheng Qin, Bangbo Zhao, Zeru Li, Tianyu Li, Weibin Wang

Cancer Letters · 2026-11 · 218930

DOI: 10.1016/j.canlet.2026.218930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-11. Verfasst von Yutong Zhao und 8 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhao, Y., Wang, Y., Zhang, X., Chen, L., Qin, C., Zhao, B., Li, Z., Li, T., & Wang, W. (2026). The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer. Cancer Letters, 218930. https://doi.org/10.1016/j.canlet.2026.218930

Vancouver

Zhao Y, Wang Y, Zhang X, Chen L, Qin C, Zhao B, et al. The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer. Cancer Letters. 2026:218930. doi:10.1016/j.canlet.2026.218930

BibTeX
@article{Zhao2026,
  author = {Zhao, Yutong and Wang, Yuanyang and Zhang, Xiangyu and Chen, Lin and Qin, Cheng and Zhao, Bangbo and Li, Zeru and Li, Tianyu and Wang, Weibin},
  title = {The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer},
  journal = {Cancer Letters},
  year = {2026},
  pages = {218930},
  doi = {10.1016/j.canlet.2026.218930}
}
Kostenlos starten →